HSBC Holdings
KURA icon

HSBC Holdings’s Kura Oncology KURA Stock Holding History

HSBC Holdings’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$736K Buy
89,032
+37,029
+71% +$318K ﹤0.01% 2027
2025
Q4 		$536K Sell
52,003
-79,189
-60% -$831K ﹤0.01% 2282
2025
Q3 		$1.15M Sell
131,192
-5,884
-4% -$41.9K ﹤0.01% 1737
2025
Q2 		$784K Buy
137,076
+82,585
+152% +$506K ﹤0.01% 1925
2025
Q1 		$351K Buy
54,491
+11,406
+26% +$88.9K ﹤0.01% 2280
2024
Q4 		$370K Buy
43,085
+26,922
+167% +$387K ﹤0.01% 2363
2024
Q3 		$316K Sell
16,163
-2,137
-12% -$43.3K ﹤0.01% 2304
2024
Q2 		$374K Buy
18,300
+2,167
+13% +$44.5K ﹤0.01% 2149
2024
Q1 		$344K Sell
16,133
-21,693
-57% -$422K ﹤0.01% 2341
2023
Q4 		$545K Buy
37,826
+4,589
+14% +$45.1K ﹤0.01% 2022
2023
Q3 		$300K Buy
+33,237
New +$337K ﹤0.01% 2217
2021
Q1 		– Sell
-6,147
Closed -$204K – 2951
2020
Q4 		$204K Buy
+6,147
New +$216K ﹤0.01% 2809

Other funds holding KURA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
PM
Prosight Management Dallas, Texas $610M AUM 40.86% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

HSBC Holdings's KURA Position: Q1 2026 in Review

HSBC Holdings increased its Kura Oncology (KURA) stake by 71% in Q1 2026, buying an estimated $318K and bringing the position to 89,032 shares worth $736K. The position accounts for ﹤0.01% of the portfolio, ranked #2027.

HSBC Holdings first reported a position in KURA in Q4 2020 and has held it in 12 quarters since. The position peaked at $1.15M in Q3 2025. 220 funds tracked by Wall St. Rank hold KURA as of Q1 2026.

  • HSBC Holdings held 89,032 shares of Kura Oncology worth $736K as of Q1 2026.
  • HSBC Holdings bought 37,029 Kura Oncology shares in Q1 2026, an estimated $318K.
  • Kura Oncology made up ﹤0.01% of HSBC Holdings's portfolio in Q1 2026, its #2027 holding.
  • HSBC Holdings first reported a position in Kura Oncology in Q4 2020 and has held it in 12 quarters since.
  • HSBC Holdings's Kura Oncology position peaked at $1.15M in Q3 2025.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q1 2026.

Based on HSBC Holdings's 13F filing for Q1 2026, filed 30 Apr 2026.